A meta-analysis of individual participant data from eligible observational studies suggested that use of any antihypertensive medications (AHM) with efficacy to lower blood pressure (BP) might reduce the risk for dementia among people with high BP. However, no evidence was found that a specific AHM drug class was more effective than others in lowering risk of dementia. The analysis included 6 prospective community-based studies (n=31 090 well phenotyped dementia-free adults > 55 years) with median follow-ups across cohorts of 7–22 years. There were 3728 incident cases of dementia and 1741 incident Alzheimer’s disease diagnoses. In the high BP stratum (n=15 537, systolic BP ≥140 mm Hg or diastolic BP ≥90 mm Hg), those using any AHM had a reduced risk for developing dementia (hazard ratio [HR] 0·88) and Alzheimer’s disease (HR 0·84) compared with those not using AHM. There was no significant differences between one drug class versus all others on risk of dementia. In the normal BP stratum (n=15 553), there was no association between AHM use and incident dementia or Alzheimer’s disease. The findings are consistent with previous and parallel studies and suggest that the beneficial effect of AHM on the risk for dementia should be considered for high BP management. Source: https://www.thelancet.com/
Higher nighttime light exposure was associated with adverse changes in cardiac structure and function and…
In two UK cohorts including 977,282 adults, drinking beverages at a “very hot” temperature was…
In a UK prospective cohort of 502,188 adults followed for a median of 13.6 years,…
Regular smoking was associated with a lower risk of Parkinson disease (PD), and among people…
Alcohol-attributable cancer deaths in the USA doubled from 11,361 in 1990 to 23,126 in 2023,…
A systematic review and meta-analysis found that the prevalence of unruptured intracranial aneurysms (UIAs) is…
This website uses cookies.